Cell Reports Impact Factor Benchmark: What the Number Does and Does Not Tell Authors
Cell Reports impact factor is 7.7. See the current rank, quartile, and what the number actually means before you submit.
Journal evaluation
Want the full picture on Cell Reports?
See scope, selectivity, submission context, and what editors actually want before you decide whether Cell Reports is realistic.
A fuller snapshot for authors
Use Cell Reports's impact factor as one signal, then stack it against selectivity, editorial speed, and the journal guide before you decide where to submit.
What this metric helps you decide
- Whether Cell Reports has the citation profile you want for this paper.
- How the journal compares to nearby options when prestige or visibility matters.
- Whether the citation upside is worth the likely selectivity and process tradeoffs.
What you still need besides JIF
- Scope fit and article-type fit, which matter more than a high number.
- Desk-rejection risk, which impact factor does not predict.
- Timeline and cost context, including APCs like $5,790 USD.
CiteScore: 15.1. These longer-window metrics help show whether the journal's citation performance is stable beyond a single JIF snapshot.
How authors actually use Cell Reports's impact factor
Use the number to place the journal in the right tier, then check the harder filters: scope fit, selectivity, and editorial speed.
Use this page to answer
- Is Cell Reports actually above your next-best alternatives, or just more famous?
- Does the prestige upside justify the likely cost, delay, and selectivity?
- Should this journal stay on the shortlist before you invest in submission prep?
Check next
- Acceptance rate: ~15-20%. High JIF does not tell you how hard triage will be.
- First decision: 5 days median. Timeline matters if you are under a grant, job, or revision clock.
- Publishing cost: $5,790 USD. Budget and institutional coverage can change the decision.
Quick answer
Cell Reports sits in the strong middle tier of Cell Press prestige: visible enough to matter, selective enough to signal quality, but not so rarefied that the impact factor alone should determine your submission strategy. The right use of the number is shortlist calibration, not hero worship.
If you are choosing between Cell Reports and nearby options, the impact factor helps answer a narrow question:
How much citation visibility and brand value do I get if the paper lands here?
It does not answer the harder and more important question:
Is this manuscript actually shaped for Cell Reports editorially?
Current metric snapshot
- Current JIF: 6.9 in the 2024 Journal Citation Reports, with five-year JIF 8.1
- Journal family context: Cell Press broad life-science open-access title
- Nearby decision set: often compared with eLife, Nature Communications, PNAS, and strong field-specific biology journals
- Submission mechanics: Cell Reports uses Cell Press author guidance and Editorial Manager; Article format is about 5,000 words with a 150-word summary, and the open-access APC is about $5,790
For this family benchmark, the principle matters more than the exact number: the page should always explain what the metric means in author terms rather than simply restating it.
Metric | Current value | Source to verify |
|---|---|---|
Journal Impact Factor | 6.9 | JCR 2024 / Cell Press metrics |
Five-year JIF | 8.1 | JCR 2024 |
CiteScore | 12.9 | Scopus metric context |
SJR | 3.796 | SCImago / Scopus metric context |
h-index | 246 | Scopus metric context |
Estimated acceptance range | 15-20% | Planning estimate, not an official Cell Press rate |
APC | $5,790 | Cell Press open-access fee context |
Article length signal | 5,000 words and 150-word summary | Cell Reports author instructions |
Submission portal | Cell Reports author information |
Metric question | Useful answer | Bad answer |
|---|---|---|
Is the journal visible enough? | Compare Cell Reports with the actual shortlist | Treat JIF as a universal prestige score |
Is the paper a fit? | Read recent papers and test the story shape | Infer fit from the metric |
Is the risk worth it? | Balance visibility, APC, review pressure, and audience | Chase the highest number still vaguely plausible |
That matrix is the working standard for this page type. The metric should help authors compare real options, not encourage a one-number submission strategy.
Impact factor trend
The Cell Reports impact factor trend matters because it shows the journal's stable place in the market rather than a one-year spike. Authors usually misread impact-factor changes as if they imply a dramatic editorial change. Most of the time, they do not.
Year | JIF | What changed |
|---|---|---|
2017 | 8.3 | Strong pre-pandemic baseline |
2018 | 8.0 | Stable broad-biology tier |
2019 | 8.1 | Similar baseline before the citation surge |
2020 | 9.4 | Pandemic-era citation lift |
2021 | 9.9 | Recent high point |
2022 | 8.8 | Down from the peak |
2023 | 7.7 | Down from 2022 as citation patterns normalized |
2024 | 6.9 | Down from 7.7, still Q1 in Cell Biology |
The 2024 JIF is down from 7.7 in 2023 and from the 9.9 peak in 2021. That does not make Cell Reports an easy target. It means the metric should be read as a steady broad-biology visibility signal rather than a Cell-level prestige signal.
A practical interpretation of the trend:
- a stable number suggests the journal's reputation and citation profile are holding steady
- a modest rise or fall may matter for optics, but rarely changes whether a manuscript belongs there
- bigger submission decisions are still driven by scope, story shape, and editorial fit
That is why impact-factor pages should include trend context, but never let trend context dominate the page.
How this benchmark was produced
This page was created by comparing the Cell Reports metric page, Cell Reports author instructions, Cell Press STAR Methods expectations, the Cell Reports journal profile, the local Cell Reports submission and review-time pages, and Manusights pre-submission review patterns for Cell Press submissions.
In our analysis of Cell Reports-targeted manuscripts, the named metric-reading failure pattern is treating the 6.9 JIF as if it were a generic mid-tier signal. We see authors over-weight the metric when the real decision is whether the paper has Cell Press-style mechanism and method transparency.
The editorial criteria states that Cell Reports publishes papers with a clear biological insight, so the Cell Press brand and STAR Methods requirements make the journal more demanding than many titles with similar metrics.
In our review work with Cell Reports metric decisions
In our review work with Cell Reports submissions, the impact-factor mistake is not that authors care about the number. The mistake is letting the number stand in for a manuscript-fit review. When we pressure-test Cell Reports shortlists, three recurring patterns decide whether the 6.9 JIF is useful evidence or just a prestige shortcut.
The JIF-as-permission pattern. Authors see a 6.9 impact factor and infer that the paper only needs to be solid. Cell Reports is not that simple. The abstract still has to state one clear biological insight, the main figures have to support the claim rather than list disconnected observations, and the methods have to be ready for Cell Press STAR structure. If the manuscript would need a new rescue experiment, a cleaner figure order, or a stronger data-availability statement before review, the JIF has not lowered the bar.
The Cell-transfer confusion. A Cell or Molecular Cell desk return can make Cell Reports look like the automatic next step. Sometimes it is, but only when the rejected paper is still a complete Cell Press story at a narrower significance level. The cover letter and introduction need to be rewritten for Cell Reports rather than forwarded unchanged. The table to inspect is the contribution table in the author's own mind: what claim survives after removing the flagship language?
The specialist-audience mismatch. Some manuscripts would earn more real readership in a lower-JIF field journal because the audience, methods, and references are too narrow for a broad Cell Press title. We check the reference list, the first figure, and the discussion for this. If only a small specialist group can evaluate the claim, the metric is probably pulling the paper away from its better home rather than helping the shortlist.
That is why this benchmark treats the JIF as a late-stage comparison input. The number becomes useful after the abstract, figures, methods, and cover letter already make a credible Cell Reports case.
How authors misuse the impact factor
The most common misuse is treating the JIF as if it predicts editorial treatment. It does not. A journal can have a strong impact factor and still reject your paper immediately because the manuscript is not shaped for that journal.
Another misuse is treating the number like a universal quality score. It is not. Citation behavior varies by field, article type, and journal ecology. That is why the same JIF can mean something different across neighboring venues.
The more mature use of the metric is comparative and strategic:
- Does this journal sit in the visibility tier I care about?
- Is the citation upside meaningfully different from the alternatives?
- Is the extra prestige actually worth the submission difficulty, APC, or slower process?
That is the level of interpretation this family should always encourage.
What this metric helps you decide
The Cell Reports impact factor is useful for three narrow decisions:
- whether the journal has enough visibility for the career or lab need attached to this paper
- how the journal compares to nearby shortlist options
- whether the citation upside feels worth the selectivity and APC tradeoffs
That is it.
It is less useful for predicting:
- desk rejection risk
- review experience
- how much mechanistic depth the editors will demand
- whether the journal is the best narrative fit for the manuscript
Authors get into trouble when they let the metric answer questions it was never built to answer.
How Cell Reports compares to nearby options
Cell Reports often sits in a practical shortlist with journals like:
- Nature Communications for authors chasing more prestige and broader brand pull
- PNAS for authors weighing a different audience and editorial culture
- eLife for authors prioritizing open science values and a different review model
- strong field journals for authors who care more about specialist audience fit than broad life-science reach
The impact factor helps position Cell Reports in that set, but the best submission decision still comes from manuscript fit.
If your paper is one disciplined biological story with good mechanistic support, Cell Reports can be a smarter target than a numerically stronger but less plausible option. A slightly higher impact factor at a less-fitting journal is not always a real upgrade.
Impact-factor decision matrix
Decision question | What the JIF can help with | What it cannot answer |
|---|---|---|
Is Cell Reports visible enough for this paper? | Whether the journal sits in a credible broad-biology tier | Whether your story fits the editor's first screen |
Should we choose Cell Reports over a field journal? | Whether broader visibility is worth the tradeoff | Whether specialist readers would value the work more |
Is Nature Communications worth trying first? | Whether the prestige gap is meaningful for your goal | Whether the paper has the breadth and completeness for that venue |
Should the APC or timeline change the decision? | Whether the visibility gain justifies the cost or delay | Whether a weak fit becomes stronger because the number is attractive |
The useful version of impact-factor analysis is comparative. It should help authors weigh visibility against fit, process, and audience. It should not turn into a scoreboard where the highest number automatically wins.
Before treating the metric as a deciding factor, run a Cell Reports journal-fit check or do the same exercise by hand: write down the two best alternative journals, the audience each reaches, and the one reason your paper belongs there. If Cell Reports cannot win that comparison without leaning on the number, the impact factor is masking a fit problem.
Readiness check
See how your manuscript scores against Cell Reports before you submit.
Run the scan with Cell Reports as your target journal. Get a fit signal alongside the IF context.
What evaluators may infer from the number
The impact factor still matters because humans use it as a shortcut. PIs, hiring committees, grant reviewers, and departments do notice where a paper lands, and the JIF can shape the first impression.
But serious evaluators also know the limits:
- a good paper in the wrong journal is still the wrong journal decision
- a respectable impact factor does not rescue a weak audience match
- a slightly lower-JIF but better-fitting venue can produce stronger real uptake
This is why the best impact-factor page should acknowledge reality without overpromising what the metric buys.
What the impact factor does not tell you
This is the section many impact-factor pages miss.
The Cell Reports JIF does not tell you:
- whether the paper is conceptually sharp enough for the editors
- whether the article type is right
- whether the figure set looks complete
- whether the manuscript still reads like it belongs at a different journal
- whether your paper is likely to stall at review
Those are submission questions, not citation-distribution questions.
That is why the best impact-factor page should always bridge into journal-fit and submission-readiness thinking.
How to use the metric on a real shortlist
If Cell Reports is one of three or four options on your shortlist, use the impact factor only after you answer:
- Which journal is the most believable editorial fit?
- Which audience do I actually need?
- Which process tradeoffs matter: speed, APC, selectivity, or brand?
Only then should the impact factor act as a tiebreaker or weighting factor.
In practice, the metric is most useful when two journals are both realistic homes and you are deciding whether the extra prestige is worth the extra risk or cost.
If you are still using the JIF to decide whether the paper belongs at Cell Reports, pause and test the manuscript instead. A Cell Reports journal-fit check is a better next step when the actual uncertainty is story shape, editor screen risk, or whether a field journal would give the work a stronger read.
The practical rule is simple: use the number late. First build the shortlist from audience and fit. Then use metrics to weigh tradeoffs among plausible homes.
This also protects the paper from metric drift. Metric drift happens when each discussion slowly moves the target upward because a neighboring journal has a slightly stronger number. The result is a shortlist built around prestige increments rather than editorial reality.
For Cell Reports, that mistake is common because the journal sits in an attractive middle zone. It is visible enough to tempt authors upward, but plausible enough that weak-fit manuscripts can still look tempting. A disciplined impact-factor page should stop that slide and return the team to the manuscript.
It should also make the career conversation more honest. A Cell Reports paper can be valuable because readers recognize the venue, but that value only arrives if the manuscript is strong enough to land there without months of avoidable delay. A better-fitting journal with slightly lower citation optics can be the stronger strategic move when timing, audience, review survival, and real readership value matter more.
Should you submit because of the number?
Not by itself.
Use this rule:
If this is your situation | What the impact factor should mean |
|---|---|
You already know the paper fits Cell Reports well | The metric is a supporting reason, not the main reason |
You are torn between Cell Reports and a nearby alternative | Use the metric as one comparison input |
You are mainly choosing the journal because the number looks respectable | That is too shallow a decision rule |
The manuscript is borderline for fit | The metric should not persuade you to submit anyway |
The goal is to keep the impact factor in proportion. Helpful, yes. Decisive, rarely.
Submit If / Think Twice If
Submit to Cell Reports if the manuscript already has one complete biological insight, the central claim is supported by mechanistic evidence rather than correlation alone, and the figures can be converted cleanly into Cell Press STAR Methods, key resources, and data-availability expectations.
Think twice if the paper is mostly descriptive, if the rescue or orthogonal validation experiment is still missing, or if the team is using the 6.9 JIF to justify a submission that would reach the right readers faster in a specialist biology journal.
Bottom line
A good impact-factor page should leave the reader with a more mature interpretation of the metric than they had at the start.
For Cell Reports, the right takeaway is:
- the journal has meaningful citation and reputation value
- the number helps position it on a realistic shortlist
- the actual submission decision still depends on fit, narrative shape, and editorial plausibility
That is the benchmark standard for this family.
The final test is whether the metric changes a real decision. If it only makes the journal feel more impressive, it is noise. If it helps you choose between two equally fitting venues, estimate the career value of broad visibility, or decide whether the extra selectivity is worth the attempt, it is doing useful work.
That is also why the page should be revisited when the shortlist changes. A metric that matters against one alternative may matter much less against another if the audience fit, APC, or review model changes.
The number should support the shortlist, not replace the shortlist. Fit still comes first, and that order matters because the metric is only useful after the editorial home is already plausible.
- Cell Reports journal profile, Manusights internal journal guide.
- Cell Reports submission guide, benchmark preparation guide.
Frequently asked questions
Cell Reports has a 2024 Journal Impact Factor of 6.9, with a five-year JIF of 8.1. Use the JCR year, not the calendar year of your search, when citing the metric.
Read the JIF with CiteScore 12.9, SJR 3.796, h-index 246, the estimated 15-20% acceptance range, the 2-4 day desk-screen statement, and the Cell Press STAR Methods requirements.
No. The metric is lower than Cell or Nature Communications, but Cell Reports still expects a complete Cell Press-style biological story with mechanistic evidence, STAR Methods, and a clear fit.
Use the impact factor only after fit is plausible. If the paper is a complete broad-biology story, the metric supports the shortlist. If the paper is narrow or descriptive, the number is a distraction.
Sources
- 1. Cell Press journal metrics, Cell Press.
- 2. Cell Reports information for authors, Cell Press.
- 3. Cell Reports journal home, Cell Press.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Your manuscript is never used to train any model.
Where to go next
Start here
Same journal, next question
- Cell Reports Submission Guide
- How to Avoid Desk Rejection at Cell Reports
- Cell Reports APC and Open Access: Current Price, GPOA Discounts, and What Authors Should Budget
- Cell Reports Medicine Impact Factor 2026: 14.0, Q1
- Cell Reports Acceptance Rate: What 15-20% Means When You're Submitting
- Cell Reports Review Time: What to Expect Before and After Peer Review